Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever
- PMID: 32886355
- DOI: 10.1111/apt.15874
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever
Comment in
-
Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply.Aliment Pharmacol Ther. 2020 Aug;52(4):719-720. doi: 10.1111/apt.15937. Aliment Pharmacol Ther. 2020. PMID: 32886376 No abstract available.
Comment on
-
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. doi: 10.1111/apt.15804. Epub 2020 Jun 7. Aliment Pharmacol Ther. 2020. PMID: 32359205 Free PMC article.
References
REFERENCES
-
- Coronavirus [Internet]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed May 20, 2020.
-
- Mao R, Liang J, Shen J, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5:425-427.
-
- Higgins PDR, Ng S, Danese S, Rao K. The risk of SARS-CoV-2 in immunosuppressed IBD patients. Crohns Colitis 360. 2020;2:otaa026.
-
- Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an International Registry. Gastroenterology. 2020; in press. https://doi.org/10.1053/j.gastro.2020.05.032
-
- Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52:276-283.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources